<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: CHTP News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=chtp</link><description>Latest Financial News for Chelsea Therapeutics Internatio</description><language>en-us</language><lastBuildDate>Wed, 16 Dec 2009 20:25:20 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhib (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091216/chtp8-k.html</link><description></description><guid isPermaLink="false">yahoo_finance/1299562782</guid><pubDate>Wed, 16 Dec 2009 20:25:20 Etc/GMT</pubDate></item><item><title>StockPreacher Initiates Independent Research Coverage for Chelsea Therapeutics International Inc. (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091216/180413.html?.v=1</link><description>DALLAS -- StockPreacher.com announces an investment report featuring Chelsea Therapeutics International Inc. . The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision.</description><guid isPermaLink="false">yahoo_finance/836126868</guid><pubDate>Wed, 16 Dec 2009 11:50:00 Etc/GMT</pubDate></item><item><title>UPDATE - Chelsea gets FDA nod to change study goal, shares up (at Reuters)</title><link>http://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh87801_2009-12-15_17-24-32_sge5be0jt_newsml&amp;rpc=44&amp;type=marketsNews</link><description></description><guid isPermaLink="false">yahoo_finance/627839346</guid><pubDate>Tue, 15 Dec 2009 17:24:32 Etc/GMT</pubDate></item><item><title>Chelsea Therapeutics Granted Approval to Change the Primary Endpoint and Increase Enrollment in Droxidopa Pivotal Study 301 (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091215/180317.html?.v=1</link><description>CHARLOTTE, N.C. -- Chelsea Therapeutics International, Ltd. announces that the FDA has agreed to allow the company to modify the primary endpoint and enroll an additional 24 patients in Study 301, a pivotal Phase III study of Droxidopa for the treatment of symptomatic neurogenic orthostatic hypotension .</description><guid isPermaLink="false">yahoo_finance/4247359334</guid><pubDate>Tue, 15 Dec 2009 13:30:00 Etc/GMT</pubDate></item><item><title>Chelsea Therapeutics Reports Subgroup Analysis of 44 Parkinson&apos;s Patients in Study 302 Shows Highly Statistically Significant Benefits of Droxidopa Therapy (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091214/180213.html?.v=1</link><description>CHARLOTTE, N.C. -- Chelsea Therapeutics International, Ltd. announced that new data from a subgroup analysis of the 44 Parkinson&apos;s Disease patients enrolled in Study 302, a Phase III withdrawal study of Droxidopa for the treatment of symptomatic neurogenic orthostatic hypotension , demonstrated a more robust response compared to the overall study population.</description><guid isPermaLink="false">yahoo_finance/3011830168</guid><pubDate>Mon, 14 Dec 2009 12:30:00 Etc/GMT</pubDate></item><item><title>Results From Chelsea Therapeutics&apos; Phase III Trial of Droxidopa in Neurogenic Orthostatic Hypotension to be Presented at 20th Annual International Symposium on the Autonomic Nervous System (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091112/178227.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2960314993</guid><pubDate>Thu, 12 Nov 2009 12:35:00 Etc/GMT</pubDate></item><item><title>Chelsea Therapeutics: There Are Safer Rebound Plays (at Seeking Alpha)</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12tajo8c9/*http%3A//seekingalpha.com/article/172704-chelsea-therapeutics-there-are-safer-rebound-plays?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/2272480012</guid><pubDate>Wed, 11 Nov 2009 10:00:35 Etc/GMT</pubDate></item><item><title>CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Financials (EDGAR Online Financials)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=chtp</link><description></description><guid isPermaLink="false">yahoo_finance/261501641</guid><pubDate>Fri, 6 Nov 2009 14:04:26 Etc/GMT</pubDate></item><item><title>Biotech Stock Mailbag: Poniard Predictions (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=1334cemf6/*http%3A//www.thestreet.com/_yahoo/story/10622803/1/biotech-stock-mailbag-poniard-predictions.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/282044458</guid><pubDate>Fri, 6 Nov 2009 12:00:00 Etc/GMT</pubDate></item><item><title>YRC Worldwide: Midday Volume Movers (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12sqp9472/*http%3A//www.thestreet.com/_yahoo/story/10621208/1/yrc-worldwide-midday-volume-movers.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/125382916</guid><pubDate>Tue, 3 Nov 2009 17:13:53 Etc/GMT</pubDate></item><item><title>Chelsea Just Got Riskier: BioBuzz (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12qao1lpn/*http%3A//www.thestreet.com/_yahoo/story/10621053/1/chelsea-just-got-riskier-biobuzz.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/3365247138</guid><pubDate>Tue, 3 Nov 2009 15:41:17 Etc/GMT</pubDate></item><item><title>The Long Trade in Chelsea Becomes Riskier: BioBuzz (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=13b411pvk/*http%3A//www.thestreet.com/_yahoo/story/10621053/1/the-long-trade-in-chelsea-becomes-riskier-biobuzz.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/1147823471</guid><pubDate>Tue, 3 Nov 2009 13:59:35 Etc/GMT</pubDate></item><item><title>Chelsea Therapeutics International Ltd. Q3 2009 Earnings Call Transcript (at Seeking Alpha)</title><link>http://us.rd.yahoo.com/finance/external/trsa/rss/SIG=13iqd8f82/*http%3A//seekingalpha.com/article/170675-chelsea-therapeutics-international-ltd-q3-2009-earnings-call-transcript?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/1053683422</guid><pubDate>Tue, 3 Nov 2009 02:27:07 Etc/GMT</pubDate></item><item><title>CHELSEA THERAPEUTICS INTERNATIONAL, LTD. Files SEC form 10-Q, Quarterly Report (EDGAR Online)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091102/chtp10-q.html</link><description></description><guid isPermaLink="false">yahoo_finance/998723475</guid><pubDate>Mon, 2 Nov 2009 21:32:19 Etc/GMT</pubDate></item><item><title>Chelsea Therapeutics Reports Third Quarter 2009 Results (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091102/177226.html?.v=1</link><description>CHARLOTTE, N.C. -- Chelsea Therapeutics International, Ltd. reported financial results for the third quarter 2009. Chelsea&apos;s management team will host a conference call this afternoon to discuss these results and present a quarterly update on the Company&apos;s development programs at 4:30 PM EST.</description><guid isPermaLink="false">yahoo_finance/2585969056</guid><pubDate>Mon, 2 Nov 2009 21:15:00 Etc/GMT</pubDate></item><item><title>[$$] 13D Filings (at Barrons.com)</title><link>http://us.rd.yahoo.com/finance/external/barrons/rss/SIG=11vu69bh0/*http%3A//online.barrons.com/article/SB125694280883319671.html?ru=yahoo&amp;mod=yahoobarrons</link><description>13D Filings</description><guid isPermaLink="false">yahoo_finance/1107858805</guid><pubDate>Mon, 2 Nov 2009 17:20:11 Etc/GMT</pubDate></item><item><title>Chelsea Therapeutics Appoints Dr. William D. Schwieterman Chief Medical Officer (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091102/177156.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/235835522</guid><pubDate>Mon, 2 Nov 2009 12:30:00 Etc/GMT</pubDate></item><item><title>Biotech Calendar: Key Dates for November (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=131e5lk48/*http%3A//www.thestreet.com/_yahoo/story/10619916/1/biotech-calendar-key-dates-for-november.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/457525129</guid><pubDate>Mon, 2 Nov 2009 12:12:12 Etc/GMT</pubDate></item><item><title>Q3 2009 CHELSEA THERAPEUTICS Earnings Release - After Market Close (CCBN)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/research/earncal/20091102.html?t=chtp</link><description></description><guid isPermaLink="false">yahoo_finance/3594630282</guid><pubDate>Mon, 2 Nov 2009 12:07:21 Etc/GMT</pubDate></item><item><title>Chelsea Therapeutics to Host Conference Call to Discuss Third Quarter 2009 Results (GlobeNewswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091028/176757.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3823516753</guid><pubDate>Wed, 28 Oct 2009 13:00:00 Etc/GMT</pubDate></item></channel></rss><!-- c16.finance.sp2.yahoo.com compressed/chunked Tue Dec 22 21:53:26 PST 2009 -->
